肿瘤细胞治疗研究
ALL SOURCES
Parallel processing of T cells and natural killer cells to enhance in vivoCAR T cell activity against blood and solid cancers.
本研究鼓励优化利用白细胞单采产物。通过将废弃的 PBMC 回收为 NK 细胞，可有效增强 CAR-T 细胞疗法，改善肿瘤清除率和生存率。
The inter-link of ageing, cancer and immunity: findings from real-world retrospective study.
本研究提供了外周血 PD-1 阳性细胞百分比的参考范围，证实了免疫细胞减少以及伴随癌症的一系列免疫变化，扩展了我们的真实世界证据，以更好地理解衰老、癌症和免疫之间的相互作用。
C-X-C Motif Chemokine Ligand 9 Correlates with Favorable Prognosis in Triple-Negative Breast Cancer by Promoting Immune Cell Infiltration.
Alterations in immune cell phenotype and cytotoxic capacity in HER2+ breast cancer patients receiving HER2-targeted neo-adjuvant therapy.
PBMCs 在新辅助治疗完成后表现出表型和功能的改变。在离体 ADCC 试验中，抗 PD-1 响应的 PBMCs 可能是治疗反应的生物标志物。
Effects of Reishimmune-S, a Fungal Immunomodulatory Peptide Supplement, on the Quality of Life and Circulating Natural Killer Cell Profiles of Patient
Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targe
我们的结果证实，CDK4/6 抑制剂削弱了对 tozinameran 的免疫应答，尽管接种了第三剂疫苗，仍增加了突破性感染的风险。当前证据建议继续努力为最脆弱的癌症患者提供加强免疫接种，包括正在接受 CDK4/6 抑制治疗的晚期乳腺癌患者。
The effects of exercise training for eight weeks on immune cell characteristics among breast cancer survivors.
在乳腺癌生存者中，经过 8 周运动训练后，大多数免疫细胞特征相对稳定。
Engineering Human MAIT Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
Identification of Immune Cell Components in Breast Tissues by a Multiparametric Flow Cytometry Approach.
CLEC10A can serve as a potential therapeutic target and its level correlates with immune infiltration in breast cancer.
共 10 条
MEMBER ACCOUNT
登录成功会直接打开下一页。
